Showing posts with label FDA. Show all posts
Showing posts with label FDA. Show all posts

February 24, 2009

Aspertame (think: Donald Rumsfield profiteer) update

New Mexico Senate
Santa Fe, New Mexico
The Honorable Frank Torti, M.D.

February 12, 2009

Acting Commissioner,
United States Food and Drug Administration
5400 Fisher's Lane
Rockville, Maryland

Dear Dr. Torti:

I am the New Mexico sponsor of the enclosed Senate Memorial 9, 2009, asking the Food and Drug Administration to rescind its approval for the artificial sweetener, aspartame.

You may know that the FDA, to its credit, turned down G.D. Searle's application for aspartame's approval from 1966 to 1981, at which point, approval was forced through the FDA at the insistence of Searle's CEO, Donald Rumsfeld.
Numerous physicians' petitions as well as many private petitions have been filed with FDA since 1981 asking for the rescinding of aspartame's approval. These have all been routinely ignored and responded to with industry assurance about how many industry financed "tests" aspartame has been through, all of which showed "aspartame to be safe."
FDA used to keep records on consumer complaints on aspartame, accruing a minimum of 92 alleged symptoms from ingesting aspartame, ranging from headaches, blurred vision, skin rashes, epilepsy and multiple sclerosis to that ultimate symptom, DEATH.

Dr. Torti, this chemical has produced a massive mountain of medical and neurodengenerative evidence, which I believe would lead you to order it removed from the market. While it is too late to do this now as a "precaution"; it is even more imperative to do this as a means of preventing further medical harm to future victims.

This Memorial is advancing in the New Mexico Senate, after being cosponsored by ten of my colleagues. A similar version of the Memorial has also been introduced by Hawaii Senator Chun Oakland, and is cosponsored by ten members of the Hawaii Senate. That resolution will create an evidentiary repository for Hawaii victims, especially those with diabetes and epileptic seizures, now statistically epidemic in Hawaii, with links to aspartame.In January 2009, Hawaii Senator Kalani English introduced SB576 in that state. It would ban aspartame entirely in Hawaii. This bill is cosponsored by an astonishing 14 members of the 25 member Hawaii Senate. At the same time, Representative Mele Carroll has introduced HB669, also banning aspartame's sale and use in Hawaii.

I realize a permanent FDA Commissioner has not yet been selected by the Obama Administration, but when one is appointed, I will send a similar letter to him/her to again request this action in order to protect the American public from further harm from a chemical that the FDA has known for 43 years is metabolized as methanol, formaldehyde, aspartic acid, phenylalanine, and the proven carcinogen, diketopiperazine.This regulatory failure of epic proportions entirely resulted from the actions of Donald Rumsfeld when he was with the original patent holder for aspartame. There is sufficient evidence to warrant such a rescinding, a situation not unlike that in 1969 when President Richard Nixon similarly ordered the FDA to take away the approval for another group of carcinogens, cyclamates, which occurred very quickly.

Our concern must be the overarching concerns of preventing further neurodengenerative and carcinogenic damage to hundreds of millions of Americans, who have no other government entity to trust and depend on than the United State Food and drug Administration!
I believe that President Obama, Congressman Bart Stupak, and Congresswoman Rosa Delauro all want to see the rebuilding of an FDA that merits the restored trust of the American people. I certainly want to see this come about, and I hope you do as well.Rescinding aspartame's FDA approval would be a major credible first step in the right direction.

Sincerely yours,
Gerald Ortiz y Pino
New Mexico State Senator
District 12Albuquerque

June 24, 2008

Important FLU and atypical antipsychotic information

Two things to keep your elderly parents away from: Being drugged at their elderly facility and the flu shot that has high levels of mercury, causes dementia and actually does not work which in some facilities are required.
If so, demand the flu shot without Thimerosal but not the live virus vaccine called "Flu mist". Eileen

See 5 minute University of Calgary video on our site: www.ProgressiveConvergence.com (how mercury degenerates the brain neurons)

and check out the 2500 suicide and homicide stories: http://www.ssristories.com/index.php



Letters to the editor: letters@nytimes.com
New York Times
Doctors Say Medication Is Overused in Dementia
By LAURIE TARKAN
June 24, 2008

Ramona Lamascola with her mother, Theresa Lamascola.
Ramona Lamascola thought she was losing her 88-year-old mother to dementia. Instead, she was losing her to overmedication.

Last fall her mother, Theresa Lamascola, of the Bronx, suffering from anxiety and confusion, was put on the antipsychotic drug Risperdal. When she had trouble walking, her daughter took her to another doctor — the younger Ms. Lamascola's own physician — who found that she had unrecognized hypothyroidism, a disorder that can contribute to dementia.

Mrs. Lamascola no longer takes antipsychotics.
Theresa Lamascola was moved to a nursing home to get these problems under control. But things only got worse. "My mother was screaming and out of it, drooling on herself and twitching," said Ms. Lamascola, a pediatric nurse. The psychiatrist in the nursing home stopped the Risperdal, which can cause twitching and vocal tics, and prescribed a sedative and two other antipsychotics.

"I knew the drugs were doing this to her," her daughter said. "I told him to stop the medications and stay away from Mom."

Not until yet another doctor took Mrs. Lamascola off the drugs did she begin to improve.

The use of antipsychotic drugs to tamp down the agitation, combative behavior and outbursts of dementia patients has soared, especially in the elderly. Sales of newer antipsychotics like Risperdal, Seroquel and Zyprexa totaled $13.1 billion in 2007, up from $4 billion in 2000, according to IMS Health, a health care information company.

Part of this increase can be traced to prescriptions in nursing homes. Researchers estimate that about a third of all nursing home patients have been given antipsychotic drugs.

The increases continue despite a drumbeat of bad publicity. A 2006 study of Alzheimer's patients found that for most patients, antipsychotics provided no significant improvement over placebos in treating aggression and delusions.

In 2005, the Food and Drug Administration ordered that the newer drugs carry a "black box" label warning of an increased risk of death. Last week, the F.D.A. required a similar warning on the labels of older antipsychotics.

The agency has not approved marketing of these drugs for older people with dementia, but they are commonly prescribed to these patients "off label." Several states are suing the top sellers of antipsychotics on charges of false and misleading marketing.

Ambre Morley, a spokeswoman for Janssen, the division of Johnson & Johnson that manufactures Risperdal, would not comment on the suits, but said: "As with any medication, the prescribing of a medication is up to a physician. We only promote our products for F.D.A.-approved indications."

Nevertheless, many doctors say misuse of the drugs is widespread. "These antipsychotics can be overused and abused," said Dr. Johnny Matson, a professor of psychology at Louisiana State University. "And there's a lot of abuse going on in a lot of these places."

Dr. William D. Smucker, a member of the American Medical Directors Association, a group of health professionals who work in nursing homes, agreed. Though the group encourages doctors to conduct a thorough assessment and prescribe antipsychotics only as a last resort, he said, "Many physicians are absent without leave in the nursing home and don't take an active role in the assessment of the patient."

Some nursing homes are trying a different approach, so-called environmental intervention. The strategies include reducing boredom, providing intellectual and physical stimulation, exercise, calming music, bringing in pets for therapy and improving how the staff approaches and talks to dementia patients.

At the Margaret Teitz Nursing and Rehabilitation Center in Queens, social workers do life reviews of patients to understand their interests, lifestyle and former occupations.

"I had a patient who used to be in fashion," said Nancy Goldwasser, the director of social services. "So we got her fabric samples. And she'd sit and look through the books, touch the fabric, and it would calm her."

But such approaches are time consuming, they do not help all patients, they can be prohibitively expensive and they will be more difficult to provide as Alzheimer's continues to increase.

"Our health care system isn't set up to address the mental, emotional and behavioral problems of the elderly," said Dr. Gary S. Moak, president of the American Association for Geriatric Psychiatry.

Nursing homes are short staffed, and insurers do not generally pay for the attentive medical care and hands-on psychosocial therapy that advocates recommend. It is much easier to use sedatives and antipsychotics, despite their side effects.

The first generation of antipsychotics, like Haldol, carry a significant risk of repetitive movement disorders and sedation. Second-generation antipsychotics, also called atypicals, are more commonly prescribed because the risk of movement disorders is lower. But they, too, can cause sedation, and they contribute to weight gain and diabetes.

Used correctly, the drugs do have a role in treating some seriously demented patients, who may be incapacitated by paranoia or are self-destructive or violent. Taking the edge off the behavior can keep them safe and living at home, rather than in a nursing home.

If patients are prescribed an antipsychotic, it should be a very low dose for the shortest period necessary, said Dr. Dillip V. Jeste, a professor of psychiatry and neuroscience at the University of California, San Diego.

It may take a few weeks or months to control behavior. In many cases, the patient can then be weaned off of the drugs or kept at a very low dose.

Some experts say another group of medications — antidementia drugs like Aricept, Exalon and Menamda — are underused. Research shows that 10 to 20 percent of Alzheimer's patients had noticeable positive responses to the drugs, and 40 percent more showed some cognitive improvement, even if it was not noticeable to an observer.
"Sometimes, it's enough to take the edge off the behavioral problems, so the family and patient can live with it and you don't expose people to much risk," said Dr. Gary J. Kennedy, director of geriatric psychiatry at the Montefiore Medical Center in the Bronx.

Other experts cite a lack of research backing these drugs for behavioral problems.

If patients begin showing behavioral symptoms of dementia, doctors said, they should have complete medical and psychiatric workups first, especially if symptoms develop suddenly.

"Just because someone is 95 does not mean one should not do a workup, especially if she's been healthy," Dr. Kennedy said.

Common causes of the symptoms include ministrokes, reparable brain hemorrhage from a mild bump on the head, hypothyroidism, dehydration, malnourishment, depression and sleep disorders.

Some doctors point out that simply paying attention to a nursing home patient can ease dementia symptoms. They note that in randomized trials of antipsychotic drugs for dementia, 30 to 60 percent of patients in the placebo groups improved.

"That's mind boggling," Dr. Jeste said. "These severely demented patients are not responding to the power of suggestion. They're responding to the attention they get when they participate in a clinical trial.

"They receive both T.L.C. and good general medical and humane care, which they did not receive until now. That's a sad commentary on the way we treat dementia patients."

To family members looking at a nursing home for an aging parent, experts recommend seeking out homes with low staff turnover, a high ratio of staff members to patients, and programs with psychosocial components.

The Medicare Web site has basic information on individual homes at www.medicare.gov/NHcompare. The National Citizens' Coalition for Nursing Home Reform, at www.nccnhr.org, offers a consumer guide to choosing a nursing home.

If medications are necessary, a family member should communicate with the prescribing doctor, learn the goal of each medication and be involved in making the decision.

Dr. Moak, of the psychiatry association, emphasized seeking out the doctor. Family members, he said, "often speak through the nursing staff, and that's a huge mistake."

Family members who are not convinced that a relative is receiving the best care should get a second opinion, as Ramona Lamascola did.

The physician she consulted, Dr. Kennedy of Montefiore, stopped her mother's antipsychotics and sedatives and prescribed Aricept.

"It's not clear whether it was getting her hypothyroid and other medical issues finally under control or getting rid of the offending medications," he said. "But she had a miraculous turnaround."

Theresa Lamascola still has dementia, but she went from confinement in a wheelchair — unable to sit still and screaming out in fear — to being able to walk with help, sit peacefully, have some memory and ability to communicate, understand subtleties of conversations and even make jokes.

Or, as her daughter put it, "I got my mother back."

Link to article: http://www.nytimes.com/2008/06/24/health/24deme.html?pagewanted=1&_r=1


27,346 Signatures Against TeenScreen. Petition: http://www.petitiononline.com/TScreen/petition.html Video: http://www.youtube.com/watch?v=RfU9puZQKBY


June 14, 2008

Update on Teen Screen

All of the documents filed in the TeenScreen lawsuit can be found here: 
<http://www.psychsearch.net/teenscreen_lawsuit.html> 
www.psychsearch.net/teenscreen_lawsuit.html 

The last entry is from Teresa Rhoades' attorney (plaintiff) asking for a 
trial by jury "to be held as soon as is expeditiously available on the 
Court's calendar" 

The Rutherford Institute filed the lawsuit in federal court in Indiana 
on behalf of the Rhoades' family whose 15-year-old daughter, Chelsea 
Rhoades, was subjected to a mental health screening examination at her 
school without her parents' knowledge or consent and then was diagnosed 
with two mental "disorders". Institute attorneys charge that school 
officials violated Michael and Teresa Rhoades' constitutional right, as 
parents, to control the care, custody and upbringing of their daughter 
when Chelsea was subjected to TeenScreen withouth their knowledge or 
consent. 

Rutherford Institute 
No Child Left Undrugged 
By John W. Whitehead 
6/9/2008 

According to autopsy reports, 4-year-old Rebecca Riley died from an 
overdose of psychiatric drugs. At age 2, Rebecca was diagnosed with 
attention deficit hyperactivity disorder (ADHD). At 3, she was diagnosed 
with bipolar disorder, also known as manic depression. By the time she 
died on Dec. 13, 2006, little Rebecca was taking Clonidine, as well as 
the anti-convulsant Depakote and the anti-psychotic Seroquel. 

John Whitehead 

What were some of the symptoms that prompted such treatment plans? As 
her mother described it, Rebecca was "constantly getting into things, 
running around, not being able to settle down." 

Rebecca's diagnosis was not a medical aberration. Her 10-year-old 
brother and 4-year-old sister were already being treated for manic 
depression. Indeed, nearly one million children are reportedly diagnosed 

as bipolar, making it more common than autism and diabetes combined. 

From 1994 to 2003, the number of children treated for bipolar disorder

increased 40 percent, a jump that many experts attribute to more doctors 

aggressively applying the diagnosis. 

An increasing number of medical officials are voicing the concern that 
children are being misdiagnosed. Dr. John McClellan, who runs a 
children's psychiatric hospital in the state of Washington, suggested 
that the bipolar diagnosis has become a catch-all for aggressive and 
troubled children. 

Likewise, child psychiatrist John Holttum believes that the definition 
of bipolar disorder is expanding. Whereas children who were seen as 
troubled or irritable 10 or 15 years ago might have been treated with 
counseling, parental training for their caregivers or other social 
interventions, children with similar symptoms today are being diagnosed 
as bipolar and treated with medication. Unfortunately, for many 
families, therapy is not even an option. According to Dr. Michael Brody, 
a child psychiatrist at the University of Maryland, since insurance 
companies often do not support therapy, most parents opt for medication. 

Not surprisingly, the pharmaceutical companies are reaping the rewards, 
aided by the medical community and the media. Bipolar disorder 
medication is typically three to five times more expensive than 
medications prescribed for other disorders, such as depression or 
anxiety. As the News Tribune of Tacoma, Wash., points out, "Furthering 
the trend is extensive marketing of atypical anti-psychotics by the 
companies that make them, and media coverage of bipolar disorder as a 
childhood disease." 

Yet many of the anti-psychotic drugs being prescribed for children have 
not been approved by the Food and Drug Administration for use on them. 
Of the two that have been approved for children, Risperdahl and Abilify, 
they've only been approved for short-term use. Nevertheless, as the News 
Tribune points out, because these drugs have been approved for adults, 
"doctors are free to prescribe drugs to anyone and in any way they see 
fit once they have been approved for some purpose." 

What this means is that in addition to being misdiagnosed, there is an 
increased likelihood that children are also being overdrugged. Concern 
about this scenario has prompted Dr. Jeffrey Thompson, chief medical 
officer for the Washington state Medicaid program, to provide more 
stringent guidelines to ensure that anti-psychotic drugs are prescribed 
to Medicaid children only when truly needed and at proper dosages. 

While Thompson's actions signal a move in the right direction, at least 
for minor-aged Medicaid recipients in his state, it will do little to 
help children in private care and in other states. 

When confronted with the numbers of children being diagnosed with 
bipolar disorder-about 800,000 in 2003, and likely much higher now-it is 
hard to know how to respond. Could that many young people truly be 
suffering from this disorder? It is tempting to lay the blame on an 
over-zealous medical community or a greedy pharmaceutical industry. 
There is no doubt that they have benefited financially from the sharp 
rise in bipolar cases among young people. 

Is it more a case of kids just being kids-noisy, rambunctious, 
hyperactive, disorderly? Or is there something else going on here? 
Curiously, one study released in 2007 indicated that among children 
diagnosed with bipolar disorder, two-thirds of them were boys. 

While there are undeniably cases where children are actually suffering 
and are helped by diagnosis and medication, I have to wonder about the 
majority. Little is said in the studies I have read about the impact 
that family life and the environment may have on the behavior of 
children diagnosed as bipolar, or even ADHD, yet they can't be ruled 
out. 

Society as a whole has become irresponsible in its duty to young people. 
Obsessed with materialism, we have handed over our young people to 
marketing mavens and corporations eager to make a quick buck. Distracted 
by entertainment, we have relinquished our children to television 
babysitters, allowing them to become turned on by and tuned into 
mindless television programs, video games and advertising that promote 
violence and premarital sex, among other unhealthy behaviors. Children 
need human touch and love. All too often, parents give them over to 
others for care. They also leave them floating in the non-real world of 
virtual reality. 

Thus, it is little wonder that so many children are out of control, 
disorderly and unable to settle down. But they shouldn't be victimized 
and punished for our neglect. Nor should they be drugged into 
compliance. Our children are screaming for help, but we're not listening 
to what they're saying. Instead, many parents are just hoping to shut 
them up-whether with drugs or entertainment-and get a little peace and 
quiet. But that's not the answer. 

A solution will not be found by passing another law. Rather, it must 
start at home and in the community. When the family breaks down, 
everything breaks down. We need to start by re-building families. 
Parents need to be parents and stop over-scheduling their children. They 
need to start spending time with them. 

Finally, parents need to say no to drugs for their children. They need 
to control what their children watch and listen to. And they need to 
take off the headphones, turn off the cell phones and try communicating 
with their children. 

Constitutional attorney and author John W. Whitehead is founder and 
president of The Rutherford Institute. His new book The Change Manifest
(Sourcebooks) will be out in August 2008. 

  _____  

27,270 Signatures Against TeenScreen. Petition: 
<http://www.petitiononline.com/TScreen/petition.html
http://www.petitiononline.com/TScreen/petition.html Video: 
<http://www.youtube.com/watch?v=RfU9puZQKBY
http://www.youtube.com/watch?v=RfU9puZQKBY

June 06, 2008

Mercury Teeth fillings info from US FDA

Mercury teeth fillings may harm some: U.S. FDA

By Susan Heavey Wed Jun 4, 7:48 PM ET

WASHINGTON (Reuters) - Silver-colored metal dental fillings contain mercury that may cause health problems in pregnant women, children and fetuses, the Food and Drug Administration said on Wednesday after settling a related lawsuit.

T

As part of the settlement with several consumer advocacy groups, the FDA agreed to alert consumers about the potential risks on its website and to issue a more specific rule next year for fillings that contain mercury, FDA spokeswoman Peper Long said.

Millions of Americans have the fillings, or amalgams, to patch cavities in their teeth.

"Dental amalgams contain mercury, which may have neurotoxic effects on the nervous systems of developing children and fetuses," the FDA said in a notice on its Web site.

"Pregnant women and persons who may have a health condition that makes them more sensitive to mercury exposure, including individuals with existing high levels of mercury bioburden, should not avoid seeking dental care, but should discuss options with their health practitioner," the agency said.

The FDA said it did not recommend that people who currently have mercury fillings get them removed.

The FDA must issue the new rules in July 2009, Long said.

Such a rule could impact makers of metal fillings, which include Dentsply International Inc and Danaher Corp unit Kerr.

The new rule will give the agency "special controls (that) can provide reasonable assurance of the safety and effectiveness of the product," Long said.

The lawsuit settlement was reached on Monday with several advocacy groups, including Moms Against Mercury, which had sought to have mercury fillings removed from the U.S. market.

While the FDA previously said various studies showed no harm from mercury fillings, some consumer groups contend the fillings can trigger a range of health problems such as multiple sclerosis and Alzheimer's disease. In 2006, an FDA advisory panel of outside experts said most people would not be harmed by them, but said the agency needed more information.

Mercury has been linked to brain and kidney damage at certain levels. Amalgams contain half mercury and half a combination of other metals.

Charles Brown, a lawyer for one of the groups called Consumers for Dental Choice, said the agency's move represented an about-face. "Gone, gone, gone are all of FDA's claims that no science exists that amalgam is unsafe," he said in a statement.

J.P. Morgan Securities Inc. analyst Ipsita Smolinski said the FDA is not likely to outright ban the fillings next year but will probably call for restrictions.

"We do believe that the agency will ask for the label to indicate that mercury is an ingredient in the filling, and that special populations should be exempt from such fillings, such as: nursing women, pregnant women, young children, and immunocompromised individuals," Smolinski wrote in a research note on Wednesday.

Fewer patients have been opting for mercury fillings in recent years, instead choosing lighter options such as tooth-colored resin composites.

Only 30 percent of fillings given to patients were mercury-filled ones as of 2003, according to the American Dental Association (ADA). Other options include glass cement and porcelain as well as other metals such as gold, but they cost more and are less durable, the group has said.

(Reporting by Susan Heavey; editing by Carol Bishopric)

April 09, 2008

Activism: support your rights to health supplements (your life may depend on it!!)

The Natural Health Products Protection Association

600 – 235 First Avenue

Kamloops, B.C.

V2C 3J4., Tel. 250-372-1404 Fax 250-374-5800,

shawn@buckleyandcompany.net


Shawn Buckley , one of the founders of the NHPPA , is a lawyer with expertise in the Food and Drugs Act and Regulations. Mr. Buckley acts primarily for manufacturers of Natural Health Products and has an enviable track record in protecting companies charged by Health Canada. www.healthcanadaexposed.com

Peter Helgason has spent the last six years as the Regulatory Affairs and Contact person for the Strauss Herb Company. He has spent the past six years networking in Canada and the world finding capable, ethical people who support the rights of small businesses, practitioners and consumers to access, manufacture and sell Natural Health Products.


"There has been a lot of talk about 60% of Natural Product License applications failing by either being refused or withdrawn after deficiency notices were sent. This is clearly a startling number as if the trend continues, it will mean that over half of the products currently on the market will have to be taken off of the market.


The Failure of Multi-Ingredient License Applications is Estimated to Become 80-90%


The current 60% failure rate for product license applications has mainly involved applications for single-ingredient products. This means that 60% of single ingredient NHPs have failed to pass Health Canada's stringent safety and efficacy standards. The difficulty in meeting Health Canada's standards increases with each ingredient. Because of this many are estimating that 80 to 90% of multi-ingredient NHPs will become illegal when their license applications fail.

What Natural Health Products Will be Left Once Health Canada is Finished Judging 60% of Single-Ingredient NHPs Illegal and 80-90% of Multi-Ingredient NHPs Illegal ?


Because Health Canada has been so slow to process license applications, NHP manufacturers and retailers have not yet had to decide what they will do when the overwhelming majority of their products are deemed illegal.

It is ominous that the NHPD has been given more funding to complete license applications and that Health Canada is hiring more enforcement officers in anticipation of an increase in enforcement activity."


bullet

Mission Statement


The Natural Health Products Protection Association is federally incorporated as a non-profit company with the sole object of:

Protecting access to Natural Health Products and Dietary Supplements.

By limiting its purpose to protecting access to Natural Health Products and Dietary Supplements, the NHPPA will focus on identifying and responding to threats facing the Natural Health Product and Dietary Supplement industry.

bullet

Structure of NHPPA


When consulting industry members on the structuring of the NHPPA, small and medium sized manufacturers voiced concern about the NHPPA being taken over by large companies if a membership organization structure was adopted. Whether or not this concern is warranted, there is a perception that some trade organizations in both Canada and the U.S. operate for the benefit of large members when the interests of large and small manufacturers conflict. For example, the Natural Products Association and the Council for Responsible Nutrition in the U.S. were cited as groups supporting the FDA’s Interim Final Rule on Good Manufacturing Practices for Dietary Supplements. Support for this Interim Final Rule is viewed as significant in that the new GMPs are expected to drive many small and medium manufacturers out of business. The FDA states in the Rule:

"We find that this final rule will have a significant economic impact on a substantial number of small entities…Establishments with above average costs, and even establishments with average costs, could be hard pressed to continue to operate. Some of these may decide it is too costly and either change product lines or go out of business. The regulatory costs of this final rule will also discourage new small businesses from entering the industry. The DS [industry] has been characterized by substantial entry of small businesses".

Because the NHPPA views the survival of small and medium manufacturers as vital to the NHP industry, it was decided to adopt a board-only structure. Voting membership will be limited to 5 to 7 members who will be responsible for electing the NHPPA Board. This will prevent the NHPPA from being taken over to promote the interests of one segment of the industry at the expense of other segments of the industry.


ensures that the NHPPA is moving in the direction its stakeholders want it to move in;

ensures that the NHPPA is getting the benefit of the input of its stakeholders, and

better positions the NHPPA to obtain the co-operation of its stakeholders in working together on initiatives the stakeholders have requested.


The NHPPA will involve its stakeholders in the decision making and direction of the organization by taking direction from an Advisory Board of stakeholders. There is currently an interim Advisory Board fulfilling this role. A final Advisory Board will be selected annually by those NHPPA stakeholders who join the NHPPA as Associates. All NHPPA Associates will also have the right to submit proposals and comments to both the Advisory Board and the NHPPA Board.



Become an NHPPA Associate
The NHPPA is inviting any person, company or group with an interest in protecting access to Natural Health Products and Dietary Supplements to join the NHPPA as Associates.
bullet
Why Join the NHPPA ?
The Natural Health Product Industry is under immediate threat. For example:
the majority of NHP License applications are being denied under Regulations that were to legitimize the industry. At this point almost 60% of license applications have been either refused or withdrawn. These are primarily license applications for single ingredient products. The NHPPA expects that the percentage of license refusals will increase to 80-90% as the NHPD starts considering multi-ingredient products. In short, the industry will remain largely illegal, or the majority of NHPs will have to be taken off of the market;
the new NHP Regulations are driving small and medium manufacturers out of business;
manufacturers continue to drop low selling Natural Health Products due to the high cost of compliance;
the NHP Regulations unduly increase the cost of products;
the NHP Regulations drive products from the market that Canadians depend upon for their health;
innovation on new products is grinding to a halt as it becomes clear that novel multi-ingredient products will not pass Health Canada’s scrutiny without drug-style evidence in the form of clinical trials;
natural health products that consumers, retailers and distributors depend upon are stopped at the border due to non-compliance with the NHP Regulations.
The NHPPA is ideally suited to deal with this immediate threat.
There is a pressing need for an organization that is positioned to take a leading role in uniting both the stakeholders and the other interest groups in the industry. The leading consumer groups have already expressed a desire to work with the NHPPA in forming a coalition. ALL OF THE LEADING CONSUMER GROUPS ARE NOT WILLING TO WORK WITH ANY OF THE EXISTING TRADE AND INTEREST GROUPS SUCH AS THE CHFA and the Canadian Coalition for Health Freedom. Several manufacturers, retailers and distributors have advised the NHPPA that they are not willing to work with the CHFA and organizations such as the Canadian Coalition for Health Freedom. The NHPPA MAY BE THE ONLY ORGANIZATION CAPABLE OF CREATING THE COALITION NECESSARY TO ADDRESS THE IMMEDIATE REGULATORY CRISIS.
The NHPPA will be able to include those stakeholders that for whatever reasons are unwilling to work with the other industry groups.
The NHPPA will seek to work with all other industry groups to bring about regulatory change and in this way can act as a bridge between those groups and stakeholders and consumer groups currently unwilling to work with them.
bullet Strategy for Immediate Regulatory Threat
The current regulatory crisis is not the issue threatening the NHP industry. Although the Natural Health Product industry is facing an immediate threat with the imposition of the drug-style NHP Regulations, there are other threats lurking in the background. These threats include:
international treaties Canada and the United States are participating in such as CODEX;
the imposition of ever stricter standards upon the industry by Health Canada and the Food and Drug Administration in the United States;
the seizure of products at the border between the United States and Canada. Currently, the main problem is U.S. products entering Canada. However, with the imposition of stricter standards on dietary supplements by the F.D.A., there is a real risk that the F.D.A. will adopt the Health Canada approach of stopping products at the border;
Stakeholders are currently not being kept up to date on these issues. NHPPA Associates will be kept up to date on these issues and will have input in to how the NHPPA should be working to protect Associates from these threats.

Contact Us
Contact us by mail at:
Natural Health Product Protection Association
#2 – 953 Laval Cres.
Kamloops, B.C. V2C 5P4

Contact us by email at: hrondeau@nhppa.org

Contact us by fax at: 866-789-1416

Killing the Migratory Birds of the Americas


American Songbirds Are Being Wiped Out by Banned Pesticides

by Leonard Doyle
The number of migratory songbirds returning to North America has gone into sharp decline due to the unregulated use of highly toxic pesticides and other chemicals across Latin America.

Ornithologists blame the demand for out-of-season fruit and vegetables and other crops in North America and Europe for the destruction of tens of millions of passerine birds. By some counts, half of the songbirds that warbled across America’s skies only 40 years ago have gone, wiped out by pesticides or loss of habitat.

Forty-six years ago, the naturalist Rachel Carson wrote Silent Spring, a study of the ravages caused to wildlife, especially birds, by DDT. The chemical’s use on American farms almost eradicated entire species, including the peregrine falcon and bald eagle.

The pesticide was banned and bird numbers recovered, but new and highly toxic pesticides banned by the US and European Union are being widely used in Latin America.

Because of changed consumer habits in Europe and the US, export-led agriculture has transformed the wintering grounds of birds into intensive farming operations producing grapes, melons and bananas as well as rice for export.

Ornithologists say another silent spring is dawning across the US as birds are being poisoned by toxic chemicals or killed as pests in their winter refuges across South and Central America as well as the Caribbean. They say that many species of songbird will never recover, and others may even become endangered or extinct if controls are not put in place or consumer habits changed.

More problems await those birds which make it home. Millions of acres of wilderness the birds use as nesting grounds have been ploughed under in the drive to grow corn for ethanol, for bio-fuel.

Some 150 species of songbirds undertake extraordinary migrations up to 12,000 miles every year as they move from the south to nesting grounds in the US and Canada every spring. Ornithologists say that almost all these species are at risk of poisoning.

The migratory songbirds in most trouble include the wood thrush, the Kentucky warbler, the eastern kingbird and the bobolink, celebrated by the 19th century American poet Emily Dickinson as “the rowdy of the meadows”.

Bridget Stutchbury, an ornithologist and professor at York University in Toronto, said: “With spring we take it for granted that the sound of the songbirds will fill the air with their cheerful sounds. But each year, as we continue to demand out-of-season fruits and vegetables, fewer and fewer songbirds will return.”

The bobolink songbird has experienced such a steep decline, it has almost fallen off the charts. The birds migrate in flocks from Argentina, Bolivia and Paraguay to the east coast of the US, feeding on grain and rice, prompting farmers to regard them as a pest. Bobolink numbers have plummeted almost 50 per cent in the past four decades, according to the North American Breeding Bird Survey.

Rosalind Renfrew, a biologist who studied bobolinks as they were feeding in rice paddies in Bolivia, found about half of the birds had been exposed to toxic chemicals banned in Europe and the US. Some 40 to 50 species, which include the barn swallow, the wood thrush the dickcissel as well as migratory birds of prey, are starting to disappear.

It is only recently that the decline has been definitively linked to the use of toxic pesticides in the Caribbean and across Latin America. “Everyone who has looked for pesticide poisoning in birds has found it,” Professor Stutchbury said. “When we count birds during our summers we are finding significant population declines in about three dozen species of songbirds.”

She wrote in the comment pages of The New York Times: “They are the modern-day canaries in the coal mine.” She said: “The imported fruits and vegetables found in our shopping carts in winter and early spring are grown with types and amounts of pesticides that would often be illegal in the United States.”

Growers are using high doses of pesticides, which the World Health Organisation calls class I toxins. These are also toxic to humans and are either restricted or banned in the US and EU. But controls in Latin American countries are easily flouted.

“I believe that if we don’t make drastic changes quite literally many birds which are common now are going to become rare,” said Professor Stutchbury.

Testing by individual EU countries and the US Food and Drug Administration reveals that fruits and vegetables imported from Latin America are three and sometimes four times as likely to violate basic standards for pesticide residues.

© 2008 The Independent


March 10, 2008

Alaska now having Zyprexa hearings ..

Lilly - Viva Zyprexa: call "Donna"


A retired medical officer with the federal Food and Drug Administration testified Friday that drug maker Eli Lilly distorted the science and downplayed the health risks of its schizophrenia drug Zyprexa to make more money.

John Gueriguian, who worked 20 years for the FDA and is now a consultant, was on the stand in Anchorage Superior Court all day Friday as an expert witness for the state of Alaska.

The state is suing Eli Lilly and Co. to recover costs to its Medicaid system for what it contends are serious health problems, including weight gain and diabetes, caused by Zyprexa. The state says the company failed to warn of troubles because it counted on Zyprexa to become its next big moneymaker.

Global sales of Zyprexa approached $4.8 billion last year.

At the FDA, Gueriguian worked for the division that oversaw diabetic drugs, not psychiatric medication, so he wasn't directly involved in oversight of Zyprexa. Lawyers working for the state hired him to analyze Lilly documents and e-mails and said it's impossible to get current FDA employees to testify.

If Lilly could show that diabetes was common for this class of drugs, then it would no longer be a special problem for Zyprexa, said a Nov. 28, 2001, company document.

Was it comparable? Tommy Fibich, a Houston attorney representing the state, asked.
Just the opposite, Gueriguian answered.

Zyprexa caused many more such problems than most similar drugs, he said.

''Simply put, it's putting profit over the concern of the consumer,'' Gueriguian told the jury.

In a 2001 guide for sales representatives, the directive from on high was clear, he said. ''Our goal and focus is on creating a market with Donna. The competition wins if we are distracted into talking about diabetes,'' the guide said.

''Donna'' was code for an effort to pitch the drug as treatment for depression and mood changes, Gueriguian said.

More

Insider says: Anyone know who was on the Viva Zyprexa Brand Team back in 2001?

Thursday, February 22, 2007

Lilly - Viva Zyprexa: peeling the onion


Back stories here.

But it just gets worse the harder one looks!

Furious Seasons has peeled off the next layer of the "Viva Zyprexa" onion.


A great piece of investigative journalism.


This is the lengthy, but excellent summary on zyprexa observations:
http://www.furiousseasons.com/archives/2007/02/the_zyprexa_chronicles_marketing_zyprexa_as_the_new_mood_
stabilizer_for_bipolar_disorder_and_downpla_1.html

November 24, 2007

Tamiflu update (surprise! surprise!)

FDA staff urge warnings for two flu drugs


WASHINGTON (Reuters) - Food and Drug Administration staffers are recommending new warnings about psychiatric events observed in some patients taking Roche Holding AG's Tamiflu and GlaxoSmithKline Plc's Relenza, according to documents released on Friday.

An FDA advisory panel will review the recommendations for the anti-viral influenza drugs at a meeting next week.

The FDA held a similar meeting two years ago in response to reports of a dozen deaths of children in Japan who had been taking Tamiflu.

Experts then found no evidence of a direct connection between the drug and the deaths, although the FDA did ultimately update Tamiflu's label to add a caution urging close monitoring of patients for abnormal behavior such as delirium or self-injury.

In documents prepared for the meeting next week and posted on the FDA's Web site, agency staff recommended that Tamiflu's label be strengthened to note: "In some cases, these behaviors resulted in serious injuries, including death, in adult and pediatric patients."

The FDA staff also reviewed Relenza, a drug in the same class as Tamiflu, recommending its label be changed to note "reports of hallucinations, delirium and abnormal behavior" observed in some patients taking the drug.

The current Relenza label has no label warning related to psychiatric events.

The FDA staff said the evidence is "conflicting" as to whether the events are medication-related, a manifestation of disease or a combination of the two.

Tamiflu has been more widely used in Japan than in the United States, and there is some evidence that the Japanese are more vigilant about reporting side effects, the FDA has said.

Tamiflu, known generically as oseltamivir, is a pill, while Relenza, generically zanamivir, is inhaled.

A Roche spokesman said no causal relationship between Tamiflu and these psychiatric events has been proven.

"Roche has extensively investigated the issue and is conducting ongoing clinical and nonclinical studies. Roche takes all adverse events reports very seriously," spokesman Terence Hurley said in a statement.

About 48 million people have taken Tamiflu worldwide, including 21 million children, since approval in 1999, he said.

A Glaxo spokeswoman said a review of premarketing and post-approval trial data showed no worrying safety signals on patients taking Relenza. The drug is a not a major revenue-generator for UK-based Glaxo.

FDA staff based its recommendations on a review of nearly 600 cases of neuropsychiatric events reported by patients on Tamiflu and 115 cases of such events by patients taking Relenza.

The FDA staff will present the advice to the advisory panel of experts meeting on Tuesday, November 27. The agency typically takes the advice of these panels but is not bound by them.

JAPAN PROBE

Japan in March warned against prescribing Tamiflu to those ages 10 to 19 as more than 100 people, mostly young, showed signs of abnormal behavior after taking the drug.

Earlier this year, Japan broadened its probe of Tamiflu to look at flu drugs Relenza and amantadine, after reports of abnormal behavior among young patients.

FDA staff reviewed recent side effect reports on amantadine and rimantadine, another flu drug in amantadine's class, but recommended no label changes. Amantadine already has a strong warning about suicide attempts and an increase in seizures seen in patients on the drug, while rimantadine notes seizure-like activity and hallucinations.

Tamiflu was having lackluster sales as a drug to prevent and treat seasonal flu but got a second life when it was the first drug to show real efficacy in treating and preventing bird flu.

The FDA staff documents for the advisory meeting were posted at:
http://www.fda.gov/ohrms/dockets/ac/07/briefing/2007-4325b-00-in dex-27and28.html

November 16, 2007

Aspartame and MSG
A Cover-up of Major Proportions


The incredibly revealing, 90-minute video documentary Sweet Misery takes us on a journey across the U.S. interviewing highly respected doctors, neurosurgeons, federal health officials, and individuals who lay out clearly the high risks of ingesting excitotoxins like aspartame (trade names NutraSweet, Equal) and MSG. They describe in detail a major cover-up by elements of government and industry to keep these risks out of the public eye. For a list of over 50 scientific studies showing the dangers of aspartame to human health, click here.

If you care about your health and the health of your family and friends, Sweet Misery is a must-watch video which can empower you to make a difference on this vital topic. Even if you only have 10 minutes, don't miss at least watching the first part of this empowering video which will show you the hidden dangers of aspartame and MSG and what you can do about it.

Sweet Misery is available for free viewing on Google at:
http://video.google.com/videoplay?docid=-566922170441334340

Sweet Misery is also available for viewing in three parts. Click on the link given: Part 1 Part 2 Part 3

October 23, 2007


More! Ever more! on GM foods!

Don't ever say I didn't warn you!!

This is HIGHLY relevant as the Competitiveness Council appears to be applauding itself over this issue at the annual meeting coming in November. Aren't they just so damned clever??

How Corporations Engineered the Non-Regulation of Dangerous Genetically Modified Foods

Government officials around the globe have been coerced, infiltrated, and paid off by the agricultural biotech giants. In Indonesia, Monsanto gave bribes and questionable payments to at least 140 officials, attempting to get their genetically modified (GM) cotton approved.[1] On the basis of this manufactured and false notion of no meaningful differences, the FDA does not require GM food safety testing.

To further justify their lack of oversight, they claimed that GM crops were "substantially equivalent" to their natural counterparts. But this concept does not hold up to scrutiny. The Royal Society of Canada described substantial equivalence as "scientifically unjustifiable and inconsistent with precautionary regulation of the technology." In sharp contrast to the FDA's position, the Royal Society of Canada said that "the default prediction" for GM crops would include "a range of collateral changes in expression of other genes, changes in the pattern of proteins produced and/or changes in metabolic activities."[11]

Fake safety assessments Biotech companies do participate in a voluntary consultation process with the FDA, but it is derided by critics as a meaningless exercise. Companies can submit whatever information they choose, and the FDA does not conduct or commission any studies of their own. Former EPA scientist Doug Gurian-Sherman, who analyzed FDA review records obtained through the Freedom of Information Act, states flatly,
"It is clear that FDA's current voluntary notification process (even if made mandatory) is not up to the task of ensuring the safety of future GE [genetically engineered] crops." He says, "The FDA consultation process does not allow the agency to require submission of data, misses obvious errors in company-submitted data summaries, provides insufficient testing guidance, and does not require sufficiently detailed data to enable the FDA to assure that GE crops are safe to eat."[12]
Similarly, a Friends of the Earth review of company and FDA documents concluded:

"If industry chooses to submit faulty, unpublishable studies, it does so without consequence. If it should respond to an agency request with deficient data, it does so without reprimand or follow-up. . . . If a company finds it disadvantageous to characterize its product, then its properties remain uncertain or unknown. If a corporation chooses to ignore scientifically sound testing standards . . . then faulty tests are conducted instead, and the results are considered legitimate. In the area of genetically engineered food regulation, the 'competent' agencies rarely if ever (know how to) conduct independent research to verify or supplement industry findings."[13]


At the end of the consultation, the FDA doesn't actually approve the crops. Rather, they issue a letter including a statement such as the following:

"Based on the safety and nutritional assessment you have conducted, it is our understanding that Monsanto has concluded that corn products derived from this new variety are not materially different in composition, safety, and other relevant parameters from corn currently on the market, and that the genetically modified corn does not raise issues that would require premarket review or approval by FDA. . . . As you are aware, it is Monsanto's responsibility to ensure that foods marketed by the firm are safe, wholesome and in compliance with all applicable legal and regulatory requirements."[14]

The National Academy of Sciences and even the pro-GM Royal Society of London[15] describe the US system as inadequate and flawed. The editor of the prestigious journal Lancet said,
"It is astounding that the US Food and Drug Administration has not changed their stance on genetically modified food adopted in 1992. . . . The policy is that genetically modified crops will receive the same consideration for potential health risks as any other new crop plant. This stance is taken despite good reasons to believe that specific risks may exist. . . . Governments should never have allowed these products into the food chain without insisting on rigorous testing for effects on health."[16]


Promoting and regulating don't mix The FDA and other regulatory agencies are officially charged with both regulating biotech products and promoting them-a clear conflict. Suzanne Wuerthele, a US EPA toxicologist, says,
"This technology is being promoted, in the face of concerns by respectable scientists and in the face of data to the contrary, by the very agencies which are supposed to be protecting human health and the environment. The bottom line in my view is that we are confronted with the most powerful technology the world has ever known, and it is being rapidly deployed with almost no thought whatsoever to its consequences."
Canadian regulators are similarly conflicted. The Royal Society of Canada reported that,
"In meetings with senior managers from the various Canadian regulatory departments . . . their responses uniformly stressed the importance of maintaining a favorable climate for the biotechnology industry to develop new products and submit them for approval on the Canadian market. . . . The conflict of interest involved in both promoting and regulating an industry or technology . . . is also a factor in the issue of maintaining the transparency, and therefore the scientific integrity, of the regulatory process. In effect, the public interest in a regulatory system that is 'science based'-that meets scientific standards of objectivity, a major aspect of which is full openness to scientific peer review-is significantly compromised when that openness is negotiated away by regulators in exchange for cordial and supportive relationships with the industries being regulated."[17]

The conflict of interest among scientists at the European Food Safety Authority (EFSA) GMO Panel is quite explicit. According to Friends of the Earth,
"One member has direct financial links with the biotech industry and others have indirect links, such as close involvement with major conferences organized by the biotech industry. Two members have even appeared in promotional videos produced by the biotech industry. . . . Several members of the Panel, including the chair Professor Kuiper, have been involved with the EU-funded ENTRANSFOOD project. The aim of this project was to agree [to] safety assessment, risk management and risk communication procedures that would 'facilitate market introduction of GMOs in Europe, and therefore bring the European industry in a competitive position.' Professor Kuiper, who coordinated the ENTRANSFOOD project, sat on a working group that also included staff from Monsanto, Bayer CropScience and Syngenta."
The report concludes that EFSA is
"being used to create a false impression of scientific agreement when the real situation is one of intense and continuing debate and uncertainty."[18]
This parallels the deceptive façade at the FDA. The pro-GM European Commission repeats the same ruse. According to leaked documents obtained by Friends of the Earth, while they privately appreciate
"the uncertainties and gaps in knowledge that exist in relation to the safety of GM crops . . . the Commission normally keeps this uncertainty concealed from the public whilst presenting its decisions about the safety of GM crops and foods as being certain and scientifically based."
Further, in private
"they frequently criticize the European Food Safety Authority (EFSA) and its assessments of the safety of GM foods and crops, even though the Commission relies on these evaluations to make recommendations to member states. . . [and] to justify its decisions to approve new GM foods."[19]
For example, the Commission privately condemned the submission information for one crop as "mixed, scarce, delivered consecutively all over years, and not convincing."
They said there is "No sufficient experimental evidence to assess the safety."[20]


Evaluations miss most health problems Although the body of safety studies on GM foods is quite small, it has verified the concerns expressed by FDA scientists and others. The gene inserted into plant DNA may produce a protein that is inherently unhealthy. The inserted gene has been found to transfer into human gut bacteria and may even end up in human cellular DNA, where it might produce its protein over the long-term. Toxic substances in GM animal feed might bioaccumulate into milk and meat products. Farmer and medical reports link GM feed to thousands of sick, sterile, and dead animals. But there is not a single government safety assessment program in the world that is competent to even identify most of these potential health problems, let alone protect its citizens from the effects.[21]

A review of approved GM crops in Canada by professor E. Ann Clark, for example, reveals that 70% (28 of 40) "of the currently available GM crops . . . have not been subjected to any actual lab or animal toxicity testing, either as refined oils for direct human consumption or indirectly as feedstuffs for livestock. The same finding pertains to all three GM tomato Decisions, the only GM flax, and to five GM corn crops." In the remaining 30% (12) of the other crops tested, animals were not fed the whole GM feed. They were given just the isolated GM protein that the plant was engineered to produce. But even this protein was not extracted from the actual GM plant. Rather, it was manufactured in genetically engineered bacteria. This method of testing would never identify problems associated with collateral damage to GM plant DNA, unpredicted changes in the GM protein, transfer of genes to bacteria or human cells, excessive herbicide residues, or accumulation of toxins in the food chain, among others. Clark asks, "Where are the trials showing lack of harm to fed livestock, or that meat and milk from livestock fed on GM feedstuffs are safe?"[22]

Epidemiologist and GM safety expert Judy Carman shows that assessments by Food Safety Australia New Zealand (FSANZ) similarly overlook serious potential problems, including cancer, birth defects, or long-term effects of nutritional deficiencies. [23]

"A review of twelve reports covering twenty-eight GM crops - four soy, three corn, ten potatoes, eight canola, one sugar beet and two cotton - revealed no feeding trials on people. In addition, one of the GM corn varieties had gone untested on animals. Some seventeen foods involved testing with only a single oral gavage (a type of forced-feeding), with observation for seven to fourteen days, and only of the substance that had been genetically engineered to appear [the GM protein], not the whole food. Such testing assumes that the only new substance that will appear in the food is the one genetically engineered to appear, that the GM plant-produced substance will act in the same manner as the tested substance that was obtained from another source [GM bacteria], and that the substance will create disease within a few days. All are untested hypotheses and make a mockery of GM proponents' claims that the risk assessment of GM foods is based on sound science. Furthermore, where the whole food was given to animals to eat, sample sizes were often very low - for example, five to six cows per group for Roundup Ready soy - and they were fed for only four weeks."[24]


Hidden information, lack of standards, and breaking laws Companies claim that their submissions to government regulators are "confidential business information" so they are kept secret. Some industry studies that have been forced into the public domain through Freedom of Information requests or lawsuits have been appalling in design and execution. This is due in part to the lack of meaningful and consistent standards required for assessments. Gurian-Sherman says of the FDA's voluntary consultation, "Some submissions are hundreds of pages long while others are only 10 or 20."[25] A Friends of the Earth report on US regulation and corporate testing practices states, "Without standardization, companies can and do design test procedures to get the results they want." [26] Regulators also reference international standards as it suits them. According to the Centre for Integrated Research in Biosafety, for example, FSANZ "relaxed adherence to international standards for safety testing when that better suited the Applicant's submitted work, and imposed international standards whenever that was a lower standard than we recommended."[27]

Regulators also break laws. The declaration of GRAS status by the FDA deviated from the Food and Cosmetic Act and years of legal precedent. In Europe, the law requires that when EFSA and member states have different opinions, they "are obliged to co-operate with a view to either resolving the divergence or preparing a joint document clarifying the contentious scientific issues and identifying the relevant uncertainties in the data."[28] According to FOE, in the case of all GM crop reviews, none of these legal obligations were followed.[29]

Humans as guinea pigs

Since GM foods are not properly tested before they enter the market, consumers are the guinea pigs. But this doesn't even qualify as an experiment. There are no controls and no monitoring. Without post-marketing surveillance, the chances of tracing health problems to GM food are low. The incidence of a disease would have to increase dramatically before it was noticed, meaning that millions may have to get sick before a change is investigated. Tracking the impact of GM foods is even more difficult in North America, where the foods are not labeled. Regulators at Health Canada announced in 2002 that they would monitor Canadians for health problems from eating GM foods. A spokesperson said, "I think it's just prudent and what the public expects, that we will keep a careful eye on the health of Canadians." But according to CBC TV news, Health Canada "abandoned that research less than a year later saying it was 'too difficult to put an effective surveillance system in place.'" The news anchor added,
"So at this point, there is little research into the health effects of genetically modified food. So will we ever know for sure if it's safe?"[30]


Not with the biotech companies in charge. Consider the following statement in a report submitted to county officials in California by pro-GM members of a task force. "[It is] generally agreed that long-term monitoring of the human health risks of GM food through epidemiological studies is not necessary because there is no scientific evidence suggesting any long-term harm from these foods."[31] Note the circular logic: Because no long-term epidemiological studies are in place, we have no evidence showing long-term harm. And since we don't have any evidence of long-term harm, we don't need studies to look for it. What are these people thinking? Insight into the pro-GM mindset was provided by Dan Glickman, the US Secretary of Agriculture under President Clinton.
"What I saw generically on the pro-biotech side was the attitude that the technology was good, and that it was almost immoral to say that it wasn't good, because it was going to solve the problems of the human race and feed the hungry and clothe the naked. . . . And there was a lot of money that had been invested in this, and if you're against it, you're Luddites, you're stupid. That, frankly, was the side our government was on. Without thinking, we had basically taken this issue as a trade issue and they, whoever 'they' were, wanted to keep our product out of their market. And they were foolish, or stupid, and didn't have an effective regulatory system. There was rhetoric like that even here in this department. You felt like you were almost an alien, disloyal, by trying to present an open-minded view on some of the issues being raised. So I pretty much spouted the rhetoric that everybody else around here spouted; it was written into my speeches."[32]


Fortunately, not everyone feels that questioning GM foods is disloyal. On the contrary, millions of people around the world are unwilling to participate in this uncontrolled experiment. They refuse to eat GM foods. Manufacturers in Europe and Japan have committed to avoid using GM ingredients. And the US natural foods industry, not waiting for the government to test or label GMOs, is now engaged in removing all remaining GM ingredients from their sector using a third party verification system. The Campaign for Healthier Eating in America will circulate non-GMO shopping guides in stores nationwide so that consumers have clear, healthy non-GMO choices. With no governmental regulation of biotech corporations, it is left to consumers to protect themselves. To learn how to opt-out of the eating GMOs and to find non-GM alternative brands, visit www.responsibletechnology.org http://www.responsibletechnology.org/ .
New Book Genetic Roulette Documents Serious Health Dangers

The sourcebook for the Campaign is the newly released Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods. With input from more than 30 scientists over two years, it presents 65 health risks of GM foods and why current safety assessments are not competent to protect us from most of them. The book documents lab animals with damage to virtually every system and organ studied; thousands of sick, sterile, or dead livestock; and people around the world who have traced toxic or allergic reactions to eating GM products, breathing GM pollen, or touching GM crops at harvest. It also exposes many incorrect assumptions that were used to support GM approvals. Organizations worldwide are presenting the book to policy makers as evidence that GM foods are unsafe and need to be removed immediately. But we don't need to wait for governments to step in. We can make healthier choices for ourselves, our families, and our schools now, and together we can inspire the tipping point for healthier, non-GM eating in America. We believe that this can be achieved within the next 24 months. *******
The GM crops sold in the US include soy (including soy lecithin used in chocolate and thousands of other products as an emulsifier), corn (including high fructose corn syrup), cottonseed and canola (both used in vegetable oil), Hawaiian papaya, and a small amount of zucchini and crook-neck squash. There is also alfalfa for cattle (the sale of which was halted by a federal judge on March 13, 2007), GM additives such as aspartame, and milk from cows treated with GM bovine growth hormone. There is not yet any GM popcorn, white corn or blue corn. And the industry is threatening to introduce GM sugar from sugar beets next year. To learn more, for online shopping guides and to find out how to get involved, go to www.ResponsibleTechnology.org http://www.responsibletechnology.org/ .

The Institute for Responsible Technology's plans to achieve the tipping point on GMOs through consumer education has inspired the Mercola.com Foundation to match donations and membership fees to the Institute at this time. Please help end the genetic engineering of our food supply by contributing to the implementation of this important project. Click here http://www.seedsofdeception.com/utility/showPage/index.cfm?objectID=gmfree , 5112 .

Jeffrey M. Smith is the author of the newly released book, Genetic Roulette: The documented health risks of genetically engineered foods. He is the director of the Institute for Responsible Technology and the Campaign for Healthier Eating in America, the international bestselling author of Seeds of Deception, and the producer of the DVD Hidden Dangers in Kids' Meals.

[1] "Monsanto Bribery Charges in Indonesia by DoJ and USSEC," Third World Network, Malaysia, Jan 27, 2005, http://www.mindfully.org/GE/2005/Monsanto-Indonesia-Bribery27jan05.htm

[2] "Greenpeace exposes Government-Monsanto nexus to cheat Indian farmers: calls on GEAC to revoke BT cotton permission," Press release, March 3, 2005, http://www.greenpeace.org/india_en/news/details?item_id=771071

[3] Jeffrey M. Smith, Seeds of Deception, (Iowa: Yes! Books, 2003), 224.

[4] See Federal Food, Drug and Cosmetic Act (FFDCA)

[5] Dan Quayle, "Speech in the Indian Treaty Room of the Old Executive Office Building," May 26, 1992.

[6] See Smith, Seeds of Deception; and for copies of FDA memos, see The Alliance for Bio-Integrity, www.biointegrity.org http://www.biointegrity.org/

[7] Steven M. Druker, "How the US Food and Drug Administration approved genetically engineered foods despite the deaths one had caused and the warnings of its own scientists about their unique risks," Alliance for Bio-Integrity, http://www.biointegrity.org/ext-summary.html

[8] Louis J. Pribyl, "Biotechnology Draft Document, 2/27/92," March 6, 1992, www.biointegrity.org http://www.biointegrity.org/ http://www.biointegrity.org/FDAdocs/04/view1.html

[9] Linda Kahl, Memo to James Maryanski about Federal Register Document "Statement of Policy: Foods from Genetically Modified Plants," Alliance for Bio-Integrity(January 8, 1992) http://www.biointegrity.org http://www.biointegrity.org/

[10] "Statement of Policy: Foods Derived from New Plant Varieties," Federal Register 57, no. 104 (May 29, 1992): 22991.

[11] "Elements of Precaution: Recommendations for the Regulation of Food Biotechnology in Canada; An Expert Panel Report on the Future of Food Biotechnology prepared by The Royal Society of Canada at the request of Health Canada Canadian Food Inspection Agency and Environment Canada" The Royal Society of Canada, January 2001.

[12] Doug Gurian-Sherman, "Holes in the Biotech Safety Net, FDA Policy Does Not Assure the Safety of Genetically Engineered Foods," Center for Science in the Public Interest, http://www.cspinet.org/new/pdf/fda_report__final.pdf

[13] Bill Freese, "The StarLink Affair, Submission by Friends of the Earth to the FIFRA Scientific Advisory Panel considering Assessment of Additional Scientific Information Concerning StarLink Corn," July 17­19, 2001.

[14] FDA Letter, Letter from Alan M. Rulis, Office of Premarket Approval, Center for Food Safety and Applied Nutrition, FDA to Dr. Kent Croon, Regulatory Affairs Manager, Monsanto Company, Sept 25, 1996. See Letter for BNF No. 34 at http://www.cfsan.fda.gov/~lrd/biocon.html

[15] See for example, "Good Enough To Eat?" New Scientist (February 9, 2002), 7.

[16] "Health risks of genetically modified foods," editorial, Lancet, 29 May 1999.

[17] "Elements of Precaution," The Royal Society of Canada, January 2001.

[18] Friends of the Earth Europe, "Throwing Caution to the Wind: A review of the European Food Safety Authority and its work on genetically modified foods and crops," November 2004.

[19] Friends of the Earth Europe and Greenpeace, "Hidden Uncertainties What the European Commission doesn't want us to know about the risks of GMOs," April 2006.

[20] European Communities submission to World Trade Organization dispute panel, 28 January 2005.

[21] Jeffrey M. Smith, Genetic Roulette: The Documented Health Risks of Genetically Engineered Foods, Yes! Books, Fairfield, IA USA 2007

[22] E. Ann Clark, "Food Safety of GM Crops in Canada: toxicity and allergenicity," GE Alert, 2000.

[23] FLRAG of the PHAA of behalf of the PHAA, "Comments to ANZFA about Applications A372, A375, A378 and A379."

[24] Judy Carman, "Is GM Food Safe to Eat?" in R. Hindmarsh, G. Lawrence, eds., Recoding Nature Critical Perspectives on Genetic Engineering (Sydney: UNSW Press, 2004): 82­93.

[25] Doug Gurian-Sherman, "Holes in the Biotech Safety Net, FDA Policy Does Not Assure the Safety of Genetically Engineered Foods," Center for Science in the Public Interest, http://www.cspinet.org/new/pdf/fda_report__final.pdf

[26] William Freese, "Genetically Engineered Crop Health Impacts Evaluation: A Critique of U.S. Regulation of Genetically Engineered Crops and Corporate Testing Practices, with a Case Study of Bt Corn," Friends of the Earth U.S., http://www.foe.org/camps/comm/safefood/gefood/index.html

[27] M. Cretenet, J. Goven, J. A. Heinemann, B. Moore, and C. Rodriguez-Beltran, "Submission on the DAR for Application A549 Food Derived from High-Lysine Corn LY038: to permit the use in food of high-lysine corn, 2006, www.inbi.canterbury.ac.nz

[28] EU Regulation 178/2002 (Article 30)

[29] Friends of the Earth Europe, "Throwing Caution to the Wind: A review of the European Food Safety Authority and its work on genetically modified foods and crops," November 2004.

[30] "Genetically modified foods, who knows how safe they are?" CBC News and Current Affairs, September 25, 2006.

[31] Mike Zelina, et al., The Health Effects of Genetically Engineered Crops on San Luis Obispo County," A Citizen Response to the SLO Health Commission GMO Task Force Report, 2006.

[32] Bill Lambrecht, Dinner at the New Gene Café, St. Martin's Press, September 2001, pg 139.

ShareThis